当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析 - 现金流量表

鲁抗医药

(600789)

  

流通市值:90.05亿  总市值:90.05亿
流通股本:8.99亿   总股本:8.99亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,758,129,493.312,514,245,995.381,216,904,382.165,279,057,839.15
  收到的税费返还37,746,605.6628,215,771.9416,545,683.2268,796,446.38
  收到其他与经营活动有关的现金105,959,319.488,626,164.1747,165,370.81171,248,822.67
  经营活动现金流入小计3,901,835,418.372,631,087,931.491,280,615,436.195,519,103,108.2
  购买商品、接受劳务支付的现金2,532,137,292.621,580,248,428.59887,950,268.433,492,970,042.75
  支付给职工以及为职工支付的现金530,362,214.65349,428,640176,717,752.51739,896,813.83
  支付的各项税费154,086,477.76115,642,659.4435,462,359.78199,350,507.22
  支付其他与经营活动有关的现金379,306,873.76273,430,924.88153,613,861.81684,067,687.27
  经营活动现金流出小计3,595,892,858.792,318,750,652.911,253,744,242.535,116,285,051.07
  经营活动产生的现金流量净额305,942,559.58312,337,278.5826,871,193.66402,818,057.13
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额94,701,901.729,084,163.258,017.420,312,302.24
  投资活动现金流入小计94,701,901.729,084,163.258,017.420,312,302.24
  购建固定资产、无形资产和其他长期资产支付的现金209,213,507.48134,413,489.7945,486,647.87279,181,894.96
  支付其他与投资活动有关的现金--22,573,647.02-
  投资活动现金流出小计209,213,507.48134,413,489.7968,060,294.89279,181,894.96
  投资活动产生的现金流量净额-114,511,605.78-105,329,326.59-68,002,277.49-258,869,592.72
三、筹资活动产生的现金流量:
  吸收投资收到的现金---17,355,157.78
  取得借款收到的现金1,349,991,458.24861,378,558.24601,000,0001,676,204,866.63
  收到其他与筹资活动有关的现金---165,000,000.99
  筹资活动现金流入小计1,349,991,458.24861,378,558.24601,000,0001,858,560,025.4
  偿还债务支付的现金1,343,807,459.73872,111,459.73589,621,459.731,713,612,444.4
  分配股利、利润或偿付利息支付的现金151,834,671.05112,050,425.7315,381,975.76233,490,591.7
  支付其他与筹资活动有关的现金---100,556,954.28
  筹资活动现金流出小计1,495,642,130.78984,161,885.46605,003,435.492,047,659,990.38
  筹资活动产生的现金流量净额-145,650,672.54-122,783,327.22-4,003,435.49-189,099,964.98
四、汇率变动对现金及现金等价物的影响4,725,522.795,177,073.161,019,984.4910,806,795.17
五、现金及现金等价物净增加额50,505,804.0589,401,697.93-44,114,534.83-34,344,705.4
  加:期初现金及现金等价物余额495,701,191.97495,701,191.97496,209,279.97530,045,897.37
  期末现金及现金等价物余额546,206,996.02585,102,889.9452,094,745.14495,701,191.97
补充资料:
  净利润-110,648,217.65-408,347,521.83
  资产减值准备-44,919,839.14-66,942,918.06
  固定资产和投资性房地产折旧-189,019,231.64-361,994,716.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-189,019,231.64-361,994,716.82
  无形资产摊销-23,289,598.57-39,609,462.13
  长期待摊费用摊销-207,786.3-405,233.53
  处置固定资产、无形资产和其他长期资产的损失--54,688.61--153,424,695.55
  固定资产报废损失-329.76-41,910.93
  公允价值变动损失-71,340--29,520
  财务费用-26,072,458.63-67,810,528.28
  投资损失-2,083,662.72-7,590,617.17
  递延所得税-1,313,955.54-6,994,720.45
  其中:递延所得税资产减少-1,313,955.54-6,994,720.45
  存货的减少-171,901,889.75--145,062,874.28
  经营性应收项目的减少--136,345,643.17--265,435,914.87
  经营性应付项目的增加--140,485,944.07--7,355,398.71
  其他-632,542.63-688,693.45
  现金的期末余额-585,102,889.9-495,701,191.97
  减:现金的期初余额-495,701,191.97-530,045,897.37
  现金及现金等价物的净增加额-89,401,697.93--34,344,705.4
公告日期2025-10-312025-08-282025-04-302025-03-22
审计意见(境内)标准无保留意见
TOP↑